Literature DB >> 31579469

An unusual case of Lyme borreliosis: Can we miss it?

Antigona Begolli Gerqari1, Mybera Ferizi1, Sadije Halimi1, Albina Ponosheci2, Arjeta Zogaj Berisha2, Idriz Gerqari3.   

Abstract

Lyme borreliosis is an infective disease that is usually transmitted to humans via biting by bacteria-infected Ixodes tick. The disease is multisystemic and the affected organs are the skin (Erythema migrans), nervous system, eyes, heart and joints. Borrelia burgdorferi is the bacterium that causes borreliosis and the hosts are rodents of the genus Apodemus. In the Balkan region, Ixodes ricinus is the most representative vector. A bite from an infected insect is the most common mode of transmitting Borrelia; however, transplacental transmission has also been documented. Pathogenesis of the disease consists of both direct and indirect mechanisms of immunological reactions which result in the production of IgM antibodies to Borrelia in the first 3-6 weeks, and production of IgG class after 6 weeks. Many skin diseases and skin symptoms mimicking Lyme borreliosis, such as dermatomycosis, erysipelas, and undefined hyperpigmentation must be elaborated and considered for borreliosis, as skin symptoms of borreliosis can imitate many of them. ©Copyright: the Author(s), 2019.

Entities:  

Keywords:  Erythema migrans; Ixodes ticks; Lyme borreliosis

Year:  2019        PMID: 31579469      PMCID: PMC6761476          DOI: 10.4081/dr.2019.8021

Source DB:  PubMed          Journal:  Dermatol Reports        ISSN: 2036-7392


Introduction

Lyme borreliosis is a disease in which the spirochete Borrelia burgdorferi causes three main skin changes: i) erythema chronicum migrans, ii) borrelial lymphocytoma, and iii) acrodermatitis chronic atrophicans. [1-3] The bacterium which causes the disease is found in rats and other rodents. The main vector of Lyme borreliosis is Ixodes ricinus, mainly transmitting disease in Europe, while in Asia Ixodes persulcatus is the main vector. Lyme borreliosis is classified in three stages: first stage with skin symptoms, second stage with erythema chronicum migrans and lymphocytoma cutis and third stage with an involvement of the central nervous system, cardiovascular system, kidneys and joints.[1,4] Here we present a very unusual case of borreliosis with skin changes in the lower abdominal region, specifically located in the suprapubic region in a clothing-covered area. The patient was unaware of any tick bite or exposure; she lives in an urban area and works in medical profession.

Case Report

A 35-year-old woman, nurse by profession, presented in our ambulant patient unit complaining about a skin problem located in the suprapubic region. The typical sign was an erythematous patch with scaling and crusting (Figure 1), and subjective symptoms like itching and burning. During the last few days the patient had treated the skin patch with an antimycotic cream, but the problem persisted and fever and myalgia accompanied the condition. The patient self-administered an antipyretic, explaining that she thought it was just a flu. By then the general practitioner referred the patient to a dermatologist. The native conventional microscopy with an addition of 20% KOH (Potassium hydroxide) indicated mycosis showing the group of spores, although there were very unspecific signs and the patient denied that she was ticked by an insect, particularly as she did not live in an area where Borrelia is endemic. We carried out the serological analyses for B. burgdorferi. Three days later we obtained the following results: IgG antibody test for B. burgdorferi 0.120 (negative under the reference range of max 0.334) and IgM positive 1.562 (reference range under 0.610). The patient was immediately prescribed the following antibiotic therapy of amoxicillin 500 mg every 6 hours for 4 weeks. The ultrasound of abdomen was performed, and consultation with neurologist, cardiologist, ophthalmologist and rheumatologist revealed that there were no pathological signs of visceral involvement. We repeated the serological tests after one month and the results showed same level of the IgG antibodies and a decrease in level of the IgM for Borrelia. The patient was advised to repeat the serological test after three months and during that period there were no more subjective symptoms, accompanied with clearing of the skin lesions (Figure 2). Furthermore, there was no increase in levels of antibodies specific for B. burgdorferi.
Figure 1.

Atypical skin lesion caused by borreliosis and located on the suprapubic region.

Figure 2.

Clearing of the lesion following the treatment for borreliosis.

Atypical skin lesion caused by borreliosis and located on the suprapubic region. Clearing of the lesion following the treatment for borreliosis.

Discussion and Conclusions

B. burgdorferi is a bacterium that can affect the tissues of many organs. The bacteria disseminate in the skin, and skin reacts with numerous skin changes that sometimes are in a discrepancy with a number of spirochetes, that is generally explained with an aggressive response of the host to an invasion of Borrelia. The clinical manifestation of borreliosis in the skin is very different.[5] Due to this fact the diagnosis of infection with B. burgdorferi can often be missed by doctors. Skin manifestations are early signs of Lyme disease,[6,7] and detecting the disease early can prevent the affection of visceral organs and joints.[1] The early signs of the disease are related to other viral or bacterial infections including fever, myalgia, and headache, followed by skin changes. It is very important to elaborate the skin symptoms which are very similar to mycotic disease, hyperpigmentation and atrophy of the skin, erythema annulare centrifugum, erythema gyratum repens, fixed drug eruptions, contact dermatitis and erysipelas. Some diseases like morphea, lichen sclerosus, [8] and Atrophoderma of Pasini and Pierini must be evaluated for Borrelia, because Borrelia infection may be the underlying disease.[8] The undiagnosed borreliosis may lead to a chronic form of the disease that is manifested with vital organ involvements including neurological manifestation, meningitis and neuropathy, myocarditis, kidney problems and arthropathy. The role, duty and responsibility of the dermatologist are to address the doubts in the disease, especially when patients come from endemic areas, even when they deny the tick bite or when skin signs are not as characteristic as those presented and described in our case. It is therefore essential not to rule out Lyme disease in individuals presenting with characteristic symptoms even in absence of history of tick bites or exposure.
  8 in total

1.  Dermatologic manifestations of Lyme disease.

Authors:  B W Berger
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct

Review 2.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

3.  Evidence for Borrelia burgdorferi in morphea and lichen sclerosus.

Authors:  S Ozkan; N Atabey; E Fetil; V Erkizan; A T Günes
Journal:  Int J Dermatol       Date:  2000-04       Impact factor: 2.736

4.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

5.  Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans.

Authors:  E Asbrink; A Hovmark
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-04

6.  Solitary borrelial lymphocytoma: report of 36 cases.

Authors:  F Strle; D Pleterski-Rigler; G Stanek; A Pejovnik-Pustinek; E Ruzic; J Cimperman
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

7.  Atypical cutaneous lesions of Lyme disease.

Authors:  Y S Wu; W F Zhang; F P Feng; B Z Wang; Y J Zhang
Journal:  Clin Exp Dermatol       Date:  1993-09       Impact factor: 3.470

Review 8.  Diagnosis of Lyme disease based on dermatologic manifestations.

Authors:  M S Malane; J M Grant-Kels; H M Feder; S W Luger
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.